For Investors

Our Experience

We have more than 50 years of in-depth experience in Biomedical R&D and technology commercialization, focusing on developing next generation in vitro diagnostic (IVD) solutions. We have the internal know-how on identifying new biomarkers that can potentially help in the prognostication of other diseases that are of global concern. 

With factors such as increased acceptance in personalized medicine by the public and increasing efforts to reduce healthcare cost, IVD continues to be on demand as it plays a vital role in supporting physicians to make necessary treatment decisions. 

Quick Facts

67%

Reduction of hospitalization burden by StratifiDen

US$3.3 Billion

Total addressable market 

11

Go-to markets

2021

Year to market

4

Hospital partners

484

Patients who tested on our biomarkers

Exit Options

The market may attach a premium to StratifiCare and reward the company with additional turns of EBITDA upon potential exit based on the following attributes:

  • Generate high margins through its intellectual property which is scalable globally

  • Capital expenditure is expected to be minimal

12.2x*

IPO Mean

Revenue Multiple

6.3x

M&A Mean Revenue Multiple

37.0x

M&A Mean EBITDA Multiple

9.7x

IPO Median Revenue Multiple

3.8x

M&A Median Revenue Multiple

12.5x

M&A Median EBITDA Multiple

*

Values exclude outliers.

Source: Mercer Capital, Yahoo Finance

Correct as at: 9th April 2019

Disclaimer: This webpage may contain forward-looking statements, relating to the Company’s operations or to the environment in which it operates, which are based on StratifiCare Inc’s operations, estimates, forecasts and projections. These statements are not guarantees of future performance, and are subjected to important risks, uncertainties, and assumptions concerning future conditions that may ultimately prove to be inaccurate or differ materially from actual future events or results.

A number of important factors could cause actual outcomes and results to differ materially from those expressed in these forward-looking statements. Consequently, investors should not place undue reliance on these forward-looking statements, which are based on StratifiCare’s current expectations, estimates, projections, beliefs, and assumptions. These forward-looking statements speak only as of the date of this webpage and are based on the information available to StratifiCare Inc. at this time. StratifiCare Inc. disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Logo _trans.png
  • Instagram - Grey Circle
  • Twitter - Grey Circle
  • Facebook - Grey Circle
  • LinkedIn - Grey Circle

© 2015-2019 StratifiCare™ Inc.